Impact of the Cachexia Index on survival and recurrence in patients undergoing surgery for gastric cancer
- 1Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-8655 Tokyo, Japan
Abstract
Purpose: This study aimed to elucidate the clinical relevance of the cachexia index (CXI), an integrative metric encompassing sarcopenia, nutritional status, and systemic inflammatory burden, in patients undergoing surgery for gastric cancer (GC).
Methods: We retrospectively reviewed 1,166 patients who underwent curative gastrectomy for GC. The CXI was calculated as follows: skeletal muscle index (SMI) × serum albumin concentration (g/dL) / neutrophil-to-lymphocyte ratio (NLR). Patients were dichotomized according to sex-specific lowest quartile cutoff values (61.6 for men and 49.2 for women). The impact of the CXI on overall survival (OS), disease-free survival (DFS), and the recurrence patterns was studied. Multivariate Cox regression analyses were performed to identify any independent predictive factors for a poor survival.
Results: A low CXI was significantly associated with advanced age (≥ 65 years), a higher comorbidity burden, an advanced pathological stage, and a higher incidence of postoperative complications. Patients in the low-CXI group had a significantly poorer OS than those in the high-CXI group (5-year OS: 63.4% vs. 78.5%, P < 0.001), with a consistently inferior survival across pathological stages I-III. A low CXI was also significantly associated with a poorer DFS (5-year DFS: 61.0% vs. 76.7%, P < 0.001). Among the patients with stage II/III disease, hematogenous recurrence occurred more frequently in the low-CXI group than in the high-CXI group (13.6% vs. 6.9%, P = 0.026). A multivariate analysis revealed that a low CXI was an independent predictor of a poor OS (HR 1.58, 95% CI: 1.20–2.07, P = 0.001).
Conclusions: The CXI is useful for predicting the survival outcomes of GC patients, irrespective of tumor stage. A low CXI was associated with a higher incidence of recurrence, especially hematogenous recurrence.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s00595-026-03393-y.
Related
- The Value of NOX3 Gene Polymorphism (Rs3749930) To Predict Lower Overall Survival of Patients with Abdominal Aortic Aneurysm Undergoing Endovascular Aneurysm Repairing Surgery
- The modified APPLE score for predicting atrial fibrillation recurrence in patients with hypertension undergoing radiofrequency ablation
- Association of albumin to neutrophil to lymphocyte ratio with survival cachexia and severe malnutrition in patients with cancer
- Early Prognostic Value of the Freiburg Index of Post-Transjugular Intrahepatic Portosystemic Shunt Survival in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation
- Health status beyond survival: clinical validation of the EuroQol-5D-3L in octogenarians undergoing abdominal surgery.
BibTeX
@article{kojima2026impact,
title = {{Impact of the Cachexia Index on survival and recurrence in patients undergoing surgery for gastric cancer}},
author = {Haruki Kojima and Kotaro Sugawara and Koichi Yagi and Shoh Yajima and Yoshiyuki Miwa and Shuichiro Oya and Asami Okamoto and Raito Asaoka and Tomoki Kaname and Yoshifumi Baba},
journal = {Surgery Today},
year = {2026},
month = jul,
doi = {10.1007/s00595-026-03393-y},
url = {https://doi.org/10.1007/s00595-026-03393-y},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Impact of the Cachexia Index on survival and recurrence in patients undergoing surgery for gastric cancer
AU - Haruki Kojima
AU - Kotaro Sugawara
AU - Koichi Yagi
AU - Shoh Yajima
AU - Yoshiyuki Miwa
AU - Shuichiro Oya
AU - Asami Okamoto
AU - Raito Asaoka
AU - Tomoki Kaname
AU - Yoshifumi Baba
PY - 2026
DA - 2026/07/13
JO - Surgery Today
DO - 10.1007/s00595-026-03393-y
UR - https://doi.org/10.1007/s00595-026-03393-y
AB - Purpose: This study aimed to elucidate the clinical relevance of the cachexia index (CXI), an integrative metric encompassing sarcopenia, nutritional status, and systemic inflammatory burden, in patients undergoing surgery for gastric cancer (GC). Methods: We retrospectively reviewed 1,166 patients who underwent curative gastrectomy for GC. The CXI was calculated as follows: skeletal muscle index (SMI) × serum albumin concentration (g/dL) / neutrophil-to-lymphocyte ratio (NLR). Patients were dichotomized according to sex-specific lowest quartile cutoff values (61.6 for men and 49.2 for women). The impact of the CXI on overall survival (OS), disease-free survival (DFS), and the recurrence patterns was studied. Multivariate Cox regression analyses were performed to identify any independent predictive factors for a poor survival. Results: A low CXI was significantly associated with advanced age (≥ 65 years), a higher comorbidity burden, an advanced pathological stage, and a higher incidence of postoperative complications. Patients in the low-CXI group had a significantly poorer OS than those in the high-CXI group (5-year OS: 63.4% vs. 78.5%, P < 0.001), with a consistently inferior survival across pathological stages I-III. A low CXI was also significantly associated with a poorer DFS (5-year DFS: 61.0% vs. 76.7%, P < 0.001). Among the patients with stage II/III disease, hematogenous recurrence occurred more frequently in the low-CXI group than in the high-CXI group (13.6% vs. 6.9%, P = 0.026). A multivariate analysis revealed that a low CXI was an independent predictor of a poor OS (HR 1.58, 95% CI: 1.20–2.07, P = 0.001). Conclusions: The CXI is useful for predicting the survival outcomes of GC patients, irrespective of tumor stage. A low CXI was associated with a higher incidence of recurrence, especially hematogenous recurrence. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s00595-026-03393-y.
SN - 0941-1291
SN - 1436-2813
ER -